182 related articles for article (PubMed ID: 28919366)
1. Prevalence and risk factors for fragility fracture in systemic mastocytosis.
Degboé Y; Eischen M; Nigon D; Apoil PA; Mailhol C; Tournier E; Laurent C; Hanssens K; Hermine O; Paul C; Laroche M; Bulai-Livideanu C
Bone; 2017 Dec; 105():219-225. PubMed ID: 28919366
[TBL] [Abstract][Full Text] [Related]
2. Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis.
Rossini M; Zanotti R; Bonadonna P; Artuso A; Caruso B; Schena D; Vecchiato D; Bonifacio M; Viapiana O; Gatti D; Senna G; Riccio A; Passalacqua G; Pizzolo G; Adami S
Bone; 2011 Oct; 49(4):880-5. PubMed ID: 21782049
[TBL] [Abstract][Full Text] [Related]
3. Higher prevalence of vertebral fractures in systemic mastocytosis, but not in cutaneous mastocytosis and idiopathic mast cell activation syndrome.
Degboé Y; Eischen M; Apoil PA; Mailhol C; Dubreuil P; Hermine O; Paul C; Bulai Livideanu C; Laroche M
Osteoporos Int; 2019 Jun; 30(6):1235-1241. PubMed ID: 30847528
[TBL] [Abstract][Full Text] [Related]
4. The Prevalence Of Osteoporosis Is Low in Adult Cutaneous Mastocytosis Patients.
Degboé Y; Severino-Freire M; Couture G; Apoil PA; Gaudenzio N; Hermine O; Ruyssen-Witrand A; Paul C; Laroche M; Constantin A; Livideanu CB
J Allergy Clin Immunol Pract; 2024 May; 12(5):1306-1312. PubMed ID: 38423295
[TBL] [Abstract][Full Text] [Related]
5. High prevalence of fractures and osteoporosis in patients with indolent systemic mastocytosis.
van der Veer E; van der Goot W; de Monchy JG; Kluin-Nelemans HC; van Doormaal JJ
Allergy; 2012 Mar; 67(3):431-8. PubMed ID: 22229787
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow tryptase as a possible diagnostic criterion for adult systemic mastocytosis.
Bulai Livideanu C; Apoil PA; Lepage B; Eischen M; Laurent C; Laharrague P; Lamant L; Tournier E; Tavitian S; Pouplard C; Recher C; Laroche M; Mailhol C; Dubreuil P; Hermine O; Blancher A; Paul C
Clin Exp Allergy; 2016 Jan; 46(1):133-41. PubMed ID: 26767494
[TBL] [Abstract][Full Text] [Related]
7. [Bone involvement in systemic mastocytosis: Report of two cases].
Florenzano P; Mezzano V; Le-Bert M; González G
Rev Med Chil; 2016 Mar; 144(3):401-5. PubMed ID: 27299829
[TBL] [Abstract][Full Text] [Related]
8. Endocrine manifestations of systemic mastocytosis in bone.
Greene LW; Asadipooya K; Corradi PF; Akin C
Rev Endocr Metab Disord; 2016 Sep; 17(3):419-431. PubMed ID: 27239674
[TBL] [Abstract][Full Text] [Related]
9. Validation of the REMA score for predicting mast cell clonality and systemic mastocytosis in patients with systemic mast cell activation symptoms.
Alvarez-Twose I; González-de-Olano D; Sánchez-Muñoz L; Matito A; Jara-Acevedo M; Teodosio C; García-Montero A; Morgado JM; Orfao A; Escribano L
Int Arch Allergy Immunol; 2012; 157(3):275-80. PubMed ID: 22042301
[TBL] [Abstract][Full Text] [Related]
10. Risk Factor Analysis of Anaphylactic Reactions in Patients With Systemic Mastocytosis.
Gülen T; Ljung C; Nilsson G; Akin C
J Allergy Clin Immunol Pract; 2017; 5(5):1248-1255. PubMed ID: 28351784
[TBL] [Abstract][Full Text] [Related]
11. Scoring the Risk of Having Systemic Mastocytosis in Adult Patients with Mastocytosis in the Skin.
Fuchs D; Kilbertus A; Kofler K; von Bubnoff N; Shoumariyeh K; Zanotti R; Bonadonna P; Scaffidi L; Doubek M; Elberink HO; Span LFR; Hermine O; Elena C; Benvenuti P; Yavuz AS; Brockow K; Zink A; Aberer E; Gorska A; Romantowski J; Hadzijusufovic E; Fortina AB; Caroppo F; Perkins C; Illerhaus A; Panse J; Vucinic V; Jawhar M; Sabato V; Triggiani M; Parente R; Bergström A; Breynaert C; Gotlib J; Reiter A; Hartmann K; Niedoszytko M; Arock M; Kluin-Nelemans HC; Sperr WR; Greul R; Valent P
J Allergy Clin Immunol Pract; 2021 Apr; 9(4):1705-1712.e4. PubMed ID: 33346151
[TBL] [Abstract][Full Text] [Related]
12. High prevalence of anaphylaxis in patients with systemic mastocytosis - a single-centre experience.
Gülen T; Hägglund H; Dahlén B; Nilsson G
Clin Exp Allergy; 2014 Jan; 44(1):121-9. PubMed ID: 24164252
[TBL] [Abstract][Full Text] [Related]
13. Telangiectasia macularis eruptiva perstans (TMEP): A form of cutaneous mastocytosis with potential systemic involvement.
Severino M; Chandesris MO; Barete S; Tournier E; Sans B; Laurent C; Apoil PA; Lamant L; Mailhol C; Laroche M; Fraitag S; Hanssens K; Dubreuil P; Hermine O; Paul C; Bulai Livideanu C
J Am Acad Dermatol; 2016 May; 74(5):885-91.e1. PubMed ID: 26899198
[TBL] [Abstract][Full Text] [Related]
14. Predictors of new fragility fractures after diagnosis of indolent systemic mastocytosis.
van der Veer E; Arends S; van der Hoek S; Versluijs JB; de Monchy JGR; Oude Elberink JNG; van Doormaal JJ
J Allergy Clin Immunol; 2014 Dec; 134(6):1413-1421. PubMed ID: 24985401
[TBL] [Abstract][Full Text] [Related]
15. Telangiectasia macularis eruptiva perstans: a neglected type of mastocytosis with exclusively cutaneous involvement? A case series.
Michelerio A; Grassi S; Elena C; Croci GA; Boveri E; Bossi G; Brazzelli V
Eur J Dermatol; 2019 Apr; 29(2):174-178. PubMed ID: 30973331
[TBL] [Abstract][Full Text] [Related]
16. Tryptase detection in bone-marrow blood: a new diagnostic tool in systemic mastocytosis.
Proelss J; Wenzel J; Ko Y; Bieber T; Bauer R
J Am Acad Dermatol; 2007 Mar; 56(3):453-7. PubMed ID: 17317486
[TBL] [Abstract][Full Text] [Related]
17. Transglutaminase 2 expressed in mast cells recruited into skin or bone marrow induces the development of pediatric mastocytosis.
Ahn YM; Hong GU; Kim SH; Lee HJ; Baek HS; Kim MN; Park KY; Ro JY
Pediatr Allergy Immunol; 2015 Aug; 26(5):438-45. PubMed ID: 25952500
[TBL] [Abstract][Full Text] [Related]
18. Frequency of isolated cutaneous involvement in adult mastocytosis: a cohort study.
Fradet M; Negretto M; Tournier E; Laurent C; Apoil PA; Evrard S; Degboe Y; Del Mas V; Lamant L; Dubreuil P; Laroche M; Mailhol C; Hermine O; Paul C; Bulai Livideanu C
J Eur Acad Dermatol Venereol; 2019 Sep; 33(9):1713-1718. PubMed ID: 31009132
[TBL] [Abstract][Full Text] [Related]
19. Hypertryptasemia and Mast Cell-Related Disorders in Severe Osteoporotic Patients.
Carosi G; Guabello G; Longhi M; Grifoni F; Passeri E; Corbetta S
Mediators Inflamm; 2020; 2020():5785378. PubMed ID: 33144848
[TBL] [Abstract][Full Text] [Related]
20. Bone lesions in systemic mastocytosis: Bone histomorphometry and histopathological mechanisms.
Bouvard B; Pascaretti-Grizon F; Legrand E; Lavigne C; Audran M; Chappard D
Morphologie; 2020 May; 104(345):97-108. PubMed ID: 32127247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
